Effects of botulinum toxin-induced paralysis on postnatal development of the supraspinatus muscle.
The mechanical environment plays an important role in musculoskeletal tissue development. The present study characterized changes in supraspinatus muscle due to removal of mechanical cues during postnatal development. An intramuscular injection of botulinum toxin type A (BTX) was used to induce and maintain paralysis in the left shoulders of mice since birth while the right shoulders received saline and served as contralateral controls. A separate group of animals was allowed to develop normally without any injections. Muscles were examined postnatally at various time points. The maximum isometric tetanic force generated by the muscle was significantly reduced in the BTX group compared to saline and normal groups. The paralyzed muscles were smaller and showed significant muscle atrophy and fat accumulation on histologic evaluation. Myogenic genes myogenin, myoD1, myf5, myf6, and fast type II myosin heavy chain (MHC) isoform were significantly upregulated while slow type I MHC isoform was significantly downregulated in the BTX group. Adipogenic genes C/EBPα, PPARγ2, leptin, and lipoprotein lipase were significantly upregulated in the BTX group. Results indicate that reduced muscle loading secondary to BTX-induced paralysis leads to fat accumulation and muscle degeneration in the developing muscle. Understanding the molecular and compositional changes in developing supraspinatus muscles may be useful for identifying and addressing the pathological changes that occur in shoulder injuries such as neonatal brachial plexus palsy.
Das
Rosalina
R
Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri, USA.
Rich
Jason
J
Kim
H Mike
HM
McAlinden
Audrey
A
Thomopoulos
Stavros
S
D050156:Adipogenesis; D000818:Animals; D000831:Animals, Newborn; D019274:Botulinum Toxins, Type A; D020516:Brachial Plexus Neuropathies / Q000503:physiopathology; D002454:Cell Differentiation; D015870:Gene Expression; D051379:Mice; D009121:Muscle Denervation; D024510:Muscle Development; D010243:Paralysis / Q000473:pathology / Q000503:physiopathology*; D017006:Rotator Cuff / Q000254:growth & development* / Q000473:pathology / Q000503:physiopathology; D015398:Signal Transduction
D019274:Botulinum Toxins, Type A
Am J Physiol Cell Physiol. 2003 Nov;285(5):C1161-73
12839833
FEBS Lett. 1998 Nov 13;439(1-2):89-92
9849884
J Physiol. 1989 Sep;416:245-54
2607450
Biotechniques. 1997 Jun;22(6):1082-6
9187757
Can J Physiol Pharmacol. 1989 Aug;67(8):879-82
2598123
J Cell Biol. 1995 Dec;131(5):1341-9
8522594
Muscle Nerve. 2002 Sep;26(3):395-403
12210370
J Bone Joint Surg Am. 2003 Feb;85(2):316-22
12571311
J Orthop Res. 2006 May;24(5):1128-35
16602109
J Electromyogr Kinesiol. 2008 Apr;18(2):276-83
17158069
J Orthop Res. 2010 Oct;28(10):1391-8
20225283
J Orthop Res. 2005 Mar;23(2):259-65
15734235
Muscle Nerve. 2006 Jan;33(1):49-60
16184607
FEBS J. 2008 May;275(9):2042-54
18384381
Curr Top Dev Biol. 2000;48:225-68
10635461
J Bone Joint Surg Am. 2009 Apr;91(4):879-91
19339573
Differentiation. 2001 Oct;68(4-5):245-53
11776477
Stem Cells Dev. 2007 Oct;16(5):857-68
17999606
J Orthop Res. 2007 Dec;25(12):1658-64
17600825
Pediatr Radiol. 2007 Feb;37(2):173-9
17180365
J Shoulder Elbow Surg. 2000 Sep-Oct;9(5):436-40
11075329
Cells Tissues Organs. 2006;182(3-4):129-42
16914916
J Orthop Res. 2007 Sep;25(9):1154-63
17506506
Pediatr Radiol. 2005 Apr;35(4):402-9
15635469
Exp Physiol. 2000 May;85(3):295-9
10825417
Muscle Nerve. 2009 Apr;39(4):472-9
19260067
Exp Physiol. 2006 Jul;91(4):747-53
16675498